Skip to main content

Journals in Cancer

HPB

  • ISSN: 1365-182X
  • 5 Year impact factor: 3.2
  • Impact factor: 2.7
To visit the HPB journal website click here: http://www.hpbonline.org/HPB is an international forum for clinical, scientific and educational communication.Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.Abstracted and Indexed in:MEDLINE®EMBASEPubMedScience Citation Index ExpandedAcademic Search (EBSCO)HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).
HPB

Journal of Geriatric Oncology

  • ISSN: 1879-4068
  • 5 Year impact factor: 2.9
  • Impact factor: 3
The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.Editor-in-Chief, Supriya Mohile, University of Rochester, USA and the Editorial Board invite you to submit a manuscript to the Journal of Geriatric Oncology. The journal welcomes the submission of manuscripts in the following categories:• Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the EditorThe Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG).Journal of Geriatric Oncology's Inclusion and Diversity Pledge This journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader?ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
Journal of Geriatric Oncology

Pathology - Research and Practice

  • ISSN: 0344-0338
  • 5 Year impact factor: 2.6
  • Impact factor: 2.9
Pathology - Research and Practice provides accessible coverage of the most recent developments across the entire field of pathology. The Journal publishes traditional morphological studies based on histopathology, including immunohistochemistry with clinical pathological correlations, if sound biostatistical data are provided. The submission of Case Reports is only encouraged for those that provide new information on the pathogenesis of the described disease based on additional molecular biological and genetic investigations. Timely reviews that focus on recent progress in pathology are highly encouraged.A main focus of Pathology - Research and Practice is publication of manuscripts from different clinical disciplines applying molecular genetic and biological techniques and focusing on innovative results, which improve the understanding of causal pathogenesis of human diseases. Investigations for better understanding of cancer diseases and new insights into molecular carcinogenesis, including translational biology of particular cancer entities, are welcome. In this context, manuscripts focusing on new molecular genetic results, but also functional molecular biological data based on cell culture investigations and animal experiments are encouraged. With this strategy, the Journal seeks to contribute to improved understandings of human disease mechanisms.
Pathology - Research and Practice

The Journal of Molecular Diagnostics

  • ISSN: 1525-1578
  • 5 Year impact factor: 3.9
  • Impact factor: 3.4
Official journal of the Association for Molecular Pathology (AMP)The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods which may be applied to diagnosis or monitoring of disease or disease predisposition.
The Journal of Molecular Diagnostics